Iantrek Secures $42M Series C for Innovative Glaucoma Therapy
Deal News | Aug 20, 2025 | USVP Management Co LLC
Iantrek, an emerging player in medical technology, has successfully closed a Series C funding round, securing $42 million to propel the launch of its pioneering interventional glaucoma therapy, AlloFlo™ Uveo. The funding was spearheaded by USVP Management Co LLC, a prominent venture capital firm recognized for investing in groundbreaking healthcare solutions. The AlloFlo™ Uveo device is designed to provide a novel approach to managing glaucoma, a condition that damages the optic nerve and can lead to vision loss or blindness. With these new funds, Iantrek aims to enhance its clinical operations and commercialize this innovative therapy, offering hope to patients worldwide affected by glaucoma. Industry experts view this as a significant stride in medical technology, potentially setting a new benchmark for glaucoma treatment.
Sectors
- Healthcare
- Medical Devices
- Venture Capital
Geography
- United States – USVP Management Co LLC, the leading investor, is based in the United States, making it relevant to the article's geographical context.
Industry
- Healthcare – The article is centered around the development and commercialization of a new medical device for glaucoma treatment, which falls under the healthcare sector.
- Medical Devices – The focus on the AlloFlo™ Uveo, an interventional device for treating glaucoma, highlights the involvement of the medical devices industry.
- Venture Capital – USVP Management Co LLC's investment in Iantrek’s Series C funding round positions the article within the venture capital industry.
Financials
- $42 Million – The amount raised by Iantrek in its Series C funding round to support the launch of AlloFlo™ Uveo.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Iantrek | Target Company | Company | Iantrek is receiving funding to develop and launch its new glaucoma therapy device, AlloFlo™ Uveo. |
| USVP Management Co LLC | Investor | Company | A venture capital firm leading the Series C funding round for Iantrek. |